Results 71 to 80 of about 4,128 (175)

Interleukins in Platelet Biology: Unraveling the Complex Regulatory Network

open access: yesPharmaceuticals
Interleukins, a diverse family of cytokines produced by various cells, play crucial roles in immune responses, immunoregulation, and a wide range of physiological and pathological processes.
Miao Huang   +10 more
doaj   +1 more source

Rapamycin and bafilomycin A1 alter autophagy and megakaryopoiesis

open access: yesPlatelets, 2017
Autophagy is an effective strategy for cell development by recycling cytoplasmic constituents. Genetic deletion of autophagy mediator Atg7 in hematopoietic stem cells (HSCs) can lead to failure of megakaryopoiesis and enhanced autophagy has been ...
Qi Wang   +6 more
doaj   +1 more source

Autoantibody-mediated desialylation impairs human thrombopoiesis and platelet lifespan

open access: yesHaematologica, 2019
Immune thrombocytopenia is a common bleeding disease caused by autoantibody-mediated accelerated platelet clearance and impaired thrombopoiesis. Accumulating evidence suggests that desialylation affects platelet life span in immune thrombocytopenia ...
Irene Marini   +8 more
doaj   +1 more source

Thrombopoiesis: At a Glance! [PDF]

open access: yesIndian Journal of Hematology and Blood Transfusion, 2020
Preeti, Tripathi, Arijit, Sen, H P, Pati
openaire   +2 more sources

Defects in TRPM7 channel function deregulate thrombopoiesis through altered cellular Mg2+ homeostasis and cytoskeletal architecture

open access: yesNature Communications, 2016
Although Mg2+is vital for platelet activation and aggregation, its regulation in these cells is still largely unknown. Here, the authors show that TRPM7, a cation channel and a protein kinase, regulates thrombopoiesis and platelet size by affecting the ...
Simon Stritt   +20 more
doaj   +1 more source

Modeling individual time courses of thrombopoiesis during multi-cyclic chemotherapy.

open access: yesPLoS Computational Biology, 2019
BACKGROUND:Thrombocytopenia is a major side-effect of cytotoxic cancer therapies. The aim of precision medicine is to develop therapy modifications accounting for the individual's risk.
Yuri Kheifetz, Markus Scholz
doaj   +1 more source

Salicylate Inhibits Thrombopoiesis in Rat Megakaryocytes by Changing the Membrane Micro-Architecture

open access: yesCellular Physiology and Biochemistry, 2015
Background/Aims: Salicylate causes drug-induced immune thrombocytopenia. However, some clinical studies indicate the presence of additional mechanisms in the drug-induced thrombocytopenia, by which the platelet production from megakaryocytes may directly
Itsuro Kazama   +6 more
doaj   +1 more source

Utility of immature platelet fraction in the Sysmex XN‐1000V for the differential diagnosis of central and peripheral thrombocytopenia in dogs and cats

open access: yesJournal of Veterinary Internal Medicine
Background The immature platelet fraction (IPF), a parameter obtained by the Sysmex XN‐1000V analyzer, is used in humans to differentiate between central (CEN) and peripheral (PER) thrombocytopenia (TP) but has not been evaluated in small animals ...
Alejandro Perez‐Ecija   +3 more
doaj   +1 more source

Human thrombopoiesis depends on Protein kinase Cδ/protein kinase Cε functional couple

open access: yesHaematologica, 2016
A deeper understanding of the molecular events driving megakaryocytopoiesis and thrombopoiesis is essential to regulate in vitro and in vivo platelet production for clinical applications.
Cecilia Carubbi   +8 more
doaj   +1 more source

Poster Sessions

open access: yes
HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Home - About - Disclaimer - Privacy